Canton Strategic Holdings
D

CNTN

1.71000
USD
-0.10
(-5.26%)
Market Closed
Last updated: · Delayed 15 min
Volume
15,848
EPS
-0
Div Yield
-
P/E
-11
Market Cap
136,255,127

Title: Canton Strategic Holdings Inc.

Sector: Healthcare
Industry: Biotechnology
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Common questions about Canton Strategic Holdings stock